Krka, d. d. (KRK.WA)
PLN 744.0
(1.64%)
PLN 744.0
(1.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 399.62 Million EUR | 4.83% |
| 2022 | 381.21 Million EUR | 7.45% |
| 2021 | 354.78 Million EUR | -9.2% |
| 2020 | 390.74 Million EUR | 42.51% |
| 2019 | 274.19 Million EUR | 17.84% |
| 2018 | 232.68 Million EUR | 17.08% |
| 2017 | 198.74 Million EUR | 62.32% |
| 2016 | 122.43 Million EUR | -38.61% |
| 2015 | 199.43 Million EUR | -27.99% |
| 2014 | 276.95 Million EUR | 21.69% |
| 2013 | 227.58 Million EUR | 18.35% |
| 2012 | 192.3 Million EUR | -10.14% |
| 2011 | 214 Million EUR | 1.2% |
| 2010 | 211.47 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 123.48 Million EUR | 8.14% |
| 2024 Q1 | 114.18 Million EUR | 47.58% |
| 2023 Q3 | 84.04 Million EUR | -27.64% |
| 2023 Q4 | 77.37 Million EUR | -7.93% |
| 2023 FY | 399.62 Million EUR | 4.83% |
| 2023 Q1 | 120.09 Million EUR | 68.79% |
| 2023 Q2 | 116.13 Million EUR | -3.29% |
| 2022 Q1 | 107.29 Million EUR | 28.47% |
| 2022 Q2 | 180.14 Million EUR | 67.89% |
| 2022 Q3 | 75.03 Million EUR | -58.35% |
| 2022 Q4 | 71.15 Million EUR | -5.17% |
| 2022 FY | 381.21 Million EUR | 7.45% |
| 2021 Q2 | 104.24 Million EUR | 8.3% |
| 2021 FY | 354.78 Million EUR | -9.2% |
| 2021 Q3 | 70.76 Million EUR | -32.12% |
| 2021 Q4 | 83.51 Million EUR | 18.02% |
| 2021 Q1 | 96.26 Million EUR | 6.97% |
| 2020 Q4 | 89.98 Million EUR | 7.04% |
| 2020 Q2 | 82.76 Million EUR | -38.2% |
| 2020 Q1 | 133.92 Million EUR | 62.11% |
| 2020 FY | 390.74 Million EUR | 42.51% |
| 2020 Q3 | 84.06 Million EUR | 1.58% |
| 2019 Q3 | 37.04 Million EUR | -54.99% |
| 2019 Q4 | 82.61 Million EUR | 123.02% |
| 2019 Q2 | 82.3 Million EUR | 13.95% |
| 2019 Q1 | 72.23 Million EUR | 4.89% |
| 2019 FY | 274.19 Million EUR | 17.84% |
| 2018 Q3 | 28.36 Million EUR | -61.43% |
| 2018 FY | 232.68 Million EUR | 17.08% |
| 2018 Q2 | 73.53 Million EUR | 18.76% |
| 2018 Q1 | 61.92 Million EUR | 25.05% |
| 2018 Q4 | 68.86 Million EUR | 142.81% |
| 2017 Q3 | 25.14 Million EUR | -69.75% |
| 2017 Q2 | 83.11 Million EUR | 102.87% |
| 2017 Q1 | 40.96 Million EUR | 79.99% |
| 2017 Q4 | 49.51 Million EUR | 96.93% |
| 2017 FY | 198.74 Million EUR | 62.32% |
| 2016 Q2 | 43.86 Million EUR | -13.04% |
| 2016 FY | 122.43 Million EUR | -38.61% |
| 2016 Q1 | 50.43 Million EUR | 21.07% |
| 2016 Q4 | 22.76 Million EUR | 323.54% |
| 2016 Q3 | 5.37 Million EUR | -87.75% |
| 2015 Q1 | 43.06 Million EUR | -60.72% |
| 2015 Q2 | 61.26 Million EUR | 42.25% |
| 2015 FY | 199.43 Million EUR | -27.99% |
| 2015 Q4 | 41.65 Million EUR | -22.05% |
| 2015 Q3 | 53.44 Million EUR | -12.77% |
| 2014 FY | 276.95 Million EUR | 21.69% |
| 2014 Q2 | 62.76 Million EUR | -0.35% |
| 2014 Q4 | 109.63 Million EUR | 163.69% |
| 2014 Q3 | 41.57 Million EUR | -33.76% |
| 2014 Q1 | 62.98 Million EUR | 3.97% |
| 2013 Q3 | 34.23 Million EUR | -53.94% |
| 2013 Q4 | 60.58 Million EUR | 76.96% |
| 2013 FY | 227.58 Million EUR | 18.35% |
| 2013 Q1 | 58.44 Million EUR | 19.52% |
| 2013 Q2 | 74.32 Million EUR | 27.17% |
| 2012 Q4 | 48.9 Million EUR | 73.38% |
| 2012 Q2 | 60.38 Million EUR | 10.16% |
| 2012 Q1 | 54.81 Million EUR | 21.73% |
| 2012 FY | 192.3 Million EUR | -10.14% |
| 2012 Q3 | 28.2 Million EUR | -53.29% |
| 2011 FY | 214 Million EUR | 1.2% |
| 2011 Q4 | 45.03 Million EUR | 0.0% |
| 2010 FY | 211.47 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Celon Pharma S.A. | -27.24 Million PLN | 1566.93% |